Insurance

By the Retiree Report Editorial Team · Updated 2026-07-08 · 7 min read

This article is general information, not medical advice. Talk with a licensed clinician before making any decision about your care.

Hearing aids in 2026: Medicare’s gap, OTC options, and plan extras

If you have Original Medicare and you’re waiting for it to help pay for hearing aids, stop waiting. In 2026, Parts A and B still cover none of the cost of the devices themselves. What has changed is everything around that gap — a legal over-the-counter market that barely existed a few years ago, and Medicare Advantage plans that fold in a hearing benefit almost as a matter of routine.

Does Original Medicare cover hearing aids in 2026?

No. Original Medicare pays nothing toward hearing aids or the exam to fit them, and that’s been true since the program was written. The exclusion is baked into the 1965 statute, which is why it takes an act of Congress to change it. Bills to add coverage get introduced most sessions and stall; as of mid-2026, none has become law.

There’s a narrow exception worth knowing. Part B will cover a diagnostic hearing and balance exam if your doctor orders it to investigate a medical problem — say, sudden hearing loss or dizziness — because that’s treated as medical care, not a shopping trip for aids. You’ll owe the usual 20% coinsurance after your deductible. But the moment the purpose is “let’s see what device you need,” coverage disappears.

So if the government won’t buy the hardware, where does that leave you? In one of two places, depending on how you get your Medicare.

The OTC market changed the price floor

For decades, a hearing aid meant a visit to an audiologist, a fitting, and a bill that could rival a used car. That changed on October 17, 2022, when a Food and Drug Administration rule created a whole new category: over-the-counter hearing aids you can buy off a shelf or online without a prescription, a medical exam, or a professional fitting.

These aren’t for everyone. According to the National Institute on Deafness and Other Communication Disorders, OTC devices are meant for adults 18 and older who have perceived mild to moderate hearing loss — the muffled-speech, “sorry, say that again” stage, not severe loss. Children and people with more serious loss still need prescription aids fitted by a professional. That distinction matters, because buying the wrong tool for a serious problem wastes money and delays real help.

What you get for that trade-off is price competition Medicare never delivered. Prescription hearing aids commonly run $2,000 to $6,000 a pair. AARP reports OTC models generally land between $200 and $1,500 a pair, with some big-box retailers selling starter devices for a couple hundred dollars. A few now use everyday earbuds and a smartphone app that runs a quick hearing check and calibrates the sound to your ears — no clinic required.

Here’s the consumer-reporter caveat, though. “OTC” is a category, not a quality guarantee. The same online search will show you a $99 amplifier next to a $1,400 device, and the marketing rarely makes the difference obvious. Before you pay, confirm the product is registered with the FDA as a hearing aid (not a “personal sound amplifier”), and buy only where you can return it. AARP suggests insisting on at least a 30-day return window; 45 days is better, because your brain needs a couple of weeks to adjust before you’ll know if a device actually helps.

What Medicare Advantage adds — and what it really covers

The other path is Medicare Advantage, the private-plan alternative to Original Medicare. Here the hearing story is very different. In 2026, roughly 95% of Medicare Advantage enrollees are in plans that offer a hearing benefit of some kind — an exam, an allowance toward aids, or both — according to KFF’s analysis of 2026 plan offerings. That’s stable versus 2025, despite worries that tighter plan payments would thin out extras.

Almost universal availability sounds great. The fine print is where it gets ordinary. A typical hearing benefit gives you a fixed dollar allowance — sometimes a few hundred dollars, sometimes more per ear — usually good only through the plan’s contracted hearing network, and often on a set replacement cycle (say, one new pair every one to three years). Many plans require prior authorization for the hearing exam. KFF notes that these supplemental benefits, hearing included, frequently sit behind prior-authorization rules, and Medicare doesn’t publish how often those requests get approved.

The comparison, in plain terms:

None of this makes Advantage automatically the better deal — those plans come with their own networks and rules that reach far beyond hearing. If you’re weighing the two systems, our explainer on Medicare Advantage vs. Original Medicare in 2026 walks through the broader trade-off, and the Medicare dental, vision, and hearing coverage gap piece covers why these three benefits keep landing outside standard Medicare.

How to actually shop this in 2026

Start with your ears, not your wallet. If your hearing loss is sudden, painful, in one ear only, or paired with dizziness, that’s a doctor visit — the kind Part B may cover — not an online purchase. For the everyday, both-ears, “TV keeps getting louder” kind of loss, an OTC device is a reasonable first try, and the low price of entry means a mistake costs you a return shipment, not thousands of dollars.

If you’re in a Medicare Advantage plan, read your Evidence of Coverage before you buy anything, and call the plan to confirm which hearing network and which specific devices the allowance applies to — buying outside the network usually forfeits the benefit. If you’re shopping for a 2026 plan during open enrollment, the Medicare Plan Finder at medicare.gov lets you filter by hearing coverage and compare the allowances side by side. And a standing reminder that isn’t legal boilerplate: this is general information, not medical advice — a doctor or licensed audiologist should sign off on anything that involves your actual hearing.

What to remember

Original Medicare still won’t pay for hearing aids in 2026, and that gap isn’t closing without new legislation. Your two realistic routes are the over-the-counter market, where mild-to-moderate loss can be handled for a few hundred to about $1,500 a pair, and a Medicare Advantage hearing allowance, available to about 95% of enrollees but boxed in by networks, caps, and prior authorization. Match the tool to the severity of your loss, protect yourself with a generous return window, and read the plan’s fine print before you spend.